Oxysterol-EBI2 signaling in immune regulation and viral infection

European Journal of Immunology

Volumn 44, Issue 7, 2014, Pages 1904-1912

  Daugvilaite, Viktorija ^a   Arfelt, Kristine Niss ^a   Benned Jensen, Tau ^a   Sailer, Andreas W ^b   Rosenkilde, Mette M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

7TM receptor; Epstein Barr virus induced gene 2; GPCR; GPR183; Oxysterols

Indexed keywords

7TM RECEPTOR; EPSTEIN-BARR VIRUS-INDUCED GENE 2; GPCR; GPR183; OXYSTEROLS;

ANIMALS; CHOLESTEROL; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; HYDROXYCHOLESTEROLS; IMMUNE SYSTEM; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84904406250     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444493     Document Type: Review

References (67)

1. Rosenkilde, M. M., Benned-Jensen, T., Andersen, H., Holst, P. J., Kledal, T. N., Luttichau, H. R., Larsen, J. K. et al., Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J. Biol. Chem. 2006. 281: 13199-13208.
2. Hopkins, A. L. and Groom, C. R., The druggable genome. Nat. Rev. Drug Discov. 2002. 1: 727-730.
3. Birkenbach, M., Josefsen, K., Yalamanchili, R., Lenoir, G. and Kieff, E., Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 1993. 67: 2209-2220.
4. Cahir-McFarland, E. D., Carter, K., Rosenwald, A., Giltnane, J. M., Henrickson, S. E., Staudt, L. M. and Kieff, E., Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J. Virol. 2004. 78: 4108-4119.
5. Dirmeier, U., Hoffmann, R., Kilger, E., Schultheiss, U., Briseno, C., Gires, O., Kieser, A. et al., Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 2005. 24: 1711-1717.
6. Hannedouche, S., Zhang, J., Yi, T., Shen, W., Nguyen, D., Pereira, J. P., Guerini, D. et al., Oxysterols direct immune cell migration via EBI2. Nature 2011. 475: 524-527.
7. Liu, C., Yang, X. V., Wu, J., Kuei, C., Mani, N. S., Zhang, L., Yu, J. et al., Oxysterols direct B-cell migration through EBI2. Nature 2011. 475: 519-523.
8. Benned-Jensen, T., Smethurst, C., Holst, P. J., Page, K. R., Sauls, H., Sivertsen, B., Schwartz, T. W. et al., Ligand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2: identification of a potent and efficacious inverse agonist. J. Biol. Chem. 2011. 286: 29292-29302.
9. Benned-Jensen, T., Madsen, C. M., Arfelt, K. N., Smethurts, C., Blanchard, A., Jepras, R. and Rosenkilde, M. M., Small molecule antagonism of oxysterol-induced Epstein-Barr virus induced gene 2 (EBI2) activation. FEBS Open. Bio. 2013. 3: 156-160.
10. Pereira, J. P., Kelly, L. M., Xu, Y. and Cyster, J. G., EBI2 mediates B cell segregation between the outer and centre follicle. Nature 2009. 460: 1122-1126.
11. Gatto, D., Paus, D., Basten, A., Mackay, C. R. and Brink, R., Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity 2009. 31: 259-269.
12. Kelly, L. M., Pereira, J. P., Yi, T., Xu, Y. and Cyster, J. G., EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues. J. Immunol. 2011. 187: 3026-3032.
13. Gatto, D., Wood, K. and Brink, R., EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center. J. Immunol. 2011. 187: 4621-4628.
14. Barroso, R., Martinez, M. L., Barrondo, S., Vega, B., Holgado, B. L., Lucas, P., Baillo, A. et al., EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5. FASEB J. 2012. 26: 4841-4854.
15. Gill, S., Chow, R. and Brown, A. J., Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 2008. 47: 391-404.
16. Janowski, B. A., Shan, B. and Russell, D. W., The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. J. Biol. Chem. 2001. 276: 45408-45416.
17. Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R. and Mangelsdorf, D. J., An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996. 383: 728-731.
18. Wang, Y., Kumar, N., Crumbley, C., Griffin, P. R. and Burris, T. P., A second class of nuclear receptors for oxysterols: regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim. Biophys. Acta 2010. 1801: 917-923.
19. Kallen, J. A., Schlaeppi, J. M., Bitsch, F., Geisse, S., Geiser, M., Delhon, I. and Fournier, B., X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 2002. 10: 1697-1707.
20. Kallen, J., Schlaeppi, J. M., Bitsch, F., Delhon, I. and Fournier, B., Crystal structure of the human RORalpha ligand binding domain in complex with cholesterol sulfate at 2.2 A. J. Biol. Chem. 2004. 279: 14033-14038.
21. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J. and Tontonoz, P., Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 2003. 9: 213-219.
22. Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., Hausner, M. A., Shih, R. et al., LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008. 134: 97-111.
23. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J. et al., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006. 126: 1121-1133.
24. Dwyer, J. R., Sever, N., Carlson, M., Nelson, S. F., Beachy, P. A. and Parhami, F., Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J. Biol. Chem. 2007. 282: 8959-8968.
25. Nedelcu, D., Liu, J., Xu, Y., Jao, C. and Salic, A., Oxysterol binding to the extracellular domain of smoothened in hedgehog signaling. Nat. Chem. Biol. 2013. 9: 557-564.
26. Nachtergaele, S., Mydock, L. K., Krishnan, K., Rammohan, J., Schlesinger, P. H., Covey, D. F. and Rohatgi, R., Oxysterols are allosteric activators of the oncoprotein smoothened. Nat. Chem. Biol. 2012. 8: 211-220.
27. Norregaard, K., Benned-Jensen, T. and Rosenkilde, M. M., EBI2, GPR18 and GPR17-three structurally related, but biologically distinct 7TM receptors. Curr. Top. Med. Chem. 2011. 11: 618-628.
28. Benned-Jensen, T., Norn, C., Laurent, S., Madsen, C. M., Larsen, H. M., Arfelt, K. N., Wolf, R. M. et al., Molecular characterization of oxysterol binding to the Epstein-Barr Virus-induced gene 2 (GPR183). J. Biol. Chem. 2012. 287: 35470-35483.
29. Zhang, L., Shih, A. Y., Yang, X. V., Kuei, C., Wu, J., Deng, X., Mani, N. S. et al., Identification of structural motifs critical for EBI2 function and homology modeling of ligand docking site. Mol. Pharmacol. 2012. 82: 1094-1103.
30. Schwartz, T. W., Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotech. 1994. 5: 434-444.
31. Ballesteros, J. A. and Weinstein, H., Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. In Sealfon, S. C. (Ed.) Receptor molecular biology, Academic Press, New York, 1995, pp 366-428.
32. Wu, B., Chien, E. Y., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R. et al., Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010. 330: 1066-1071.
33. Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G., Desale, H. et al., Crystal structure of a lipid G protein-coupled receptor. Science 2012. 335: 851-855.
34. Spann, N. J. and Glass, C. K., Sterols and oxysterols in immune cell function. Nat. Immunol. 2013. 14: 893-900.
35. Gatto, D. and Brink, R., B cell localization: regulation by EBI2 and its oxysterol ligand. Trends Immunol. 2013. 34: 336-341.
36. Shaffer, A. L., Rosenwald, A., Hurt, E. M., Giltnane, J. M., Lam, L. T., Pickeral, O. K. and Staudt, L. M., Signatures of the immune response. Immunity 2001. 15: 375-385.
37. Yi, T., Wang, X., Kelly, L. M., An, J., Xu, Y., Sailer, A. W., Gustafsson, J. A. et al., Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 2012. 37: 535-548.
38. Yi, T. and Cyster, J. G., EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. Elife 2013. 2: e00757.
39. Gatto, D., Wood, K., Caminschi, I., Murphy-Durland, D., Schofield, P., Christ, D., Karupiah, G. et al., The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat. Immunol. 2013. 14: 446-453.
40. Chiang, E. Y., Johnston, R. J. and Grogan, J. L., EBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cells. PLoS ONE 2013. 8: e83457.
41. Preuss, I., Ludwig, M. G., Baumgarten, B., Bassilana, F., Gessier, F., Seuwen, K. and Sailer, A. W., Transcriptional regulation and functional characterization of the oxysterol/EBI2 system in primary human macrophages. Biochem. Biophys. Res. Commun. 2014. 446: 663-668.
42. Eibinger, G., Fauler, G., Bernhart, E., Frank, S., Hammer, A., Wintersperger, A., Eder, H. et al., On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment. Exp. Cell Res. 2013. 319: 1828-1838.
43. Nau, G. J., Richmond, J. F., Schlesinger, A., Jennings, E. G., Lander, E. S. and Young, R. A., Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 2002. 99: 1503-1508.
44. Park, K. and Scott, A. L., Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 2010. 88: 1081-1087.
45. Diczfalusy, U., Olofsson, K. E., Carlsson, A. M., Gong, M., Golenbock, D. T., Rooyackers, O., Flaring, U. et al., Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 2009. 50: 2258-2264.
46. Liu, S. Y., Aliyari, R., Chikere, K., Li, G., Marsden, M. D., Smith, J. K., Pernet, O. et al., Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 2013. 38: 92-105.
47. Blanc, M., Hsieh, W. Y., Robertson, K. A., Kropp, K. A., Forster, T., Shui, G., Lacaze, P. et al., The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 2013. 38: 106-118.
48. Rosenkilde, M. M. and Kledal, T. N., Targeting herpesvirus reliance of the chemokine system. Curr. Drug Targets 2006. 7: 103-118.
49. Rickinson, A. and Kieff, E., Epstein-Barr Virus. In Knipe, D. M. and Howley, P. M. (Eds.), Fields virology, vol. 2, Lippincott Williams & Wilkins, Philadelphia 2001, pp 2575-2627.
50. Epstein, M. A., Achong, B. G. and Barr, Y. M., Virus particles in cultured lymphoblasts from burkitt's lymphoma. Lancet 1964. 1: 702-703.
51. Kuppers, R., B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 2003. 3: 801-812.
52. Thorley-Lawson, D. A., Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001. 1: 75-82.
53. Kurth, J., Spieker, T., Wustrow, J., Strickler, G. J., Hansmann, L. M., Rajewsky, K. and Kuppers, R., EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 2000. 13: 485-495.
54. Wang, D., Liebowitz, D. and Kieff, E., An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985. 43: 831-840.
55. Kulwichit, W., Edwards, R. H., Davenport, E. M., Baskar, J. F., Godfrey, V. and Raab-Traub, N., Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. USA 1998. 95: 11963-11968.
56. Griffiths, W. J., Crick, P. J. and Wang, Y., Methods for oxysterol analysis: past, present and future. Biochem. Pharmacol. 2013. 86: 3-14.
57. Bauman, D. R., Bitmansour, A. D., McDonald, J. G., Thompson, B. M., Liang, G. and Russell, D. W., 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. USA 2009. 106: 16764-16769.
58. McGonagle, D. and McDermott, M. F., A proposed classification of the immunological diseases. PLoS Med. 2006. 3: e297.
59. Eizirik, D. L., Colli, M. L. and Ortis, F., The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 2009. 5: 219-226.
60. Bluestone, J. A., Herold, K. and Eisenbarth, G., Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010. 464: 1293-1300.
61. Berer, K., Wekerle, H. and Krishnamoorthy, G., B cells in spontaneous autoimmune diseases of the central nervous system. Mol. Immunol. 2011. 48: 1332-1337.
62. Heinig, M., Petretto, E., Wallace, C., Bottolo, L., Rotival, M., Lu, H., Li, Y. et al., A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010. 467: 460-464.
63. Moore, K. J. and Tabas, I., Macrophages in the pathogenesis of atherosclerosis. Cell 2011. 145: 341-355.
64. Brown, A. J. and Jessup, W., Oxysterols and atherosclerosis. Atherosclerosis 1999. 142: 1-28.
65. Moore, K. J., Sheedy, F. J. and Fisher, E. A., Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 2013. 13: 709-721.
66. Craig, F. E., Johnson, L. R., Harvey, S. A., Nalesnik, M. A., Luo, J. H., Bhattacharya, S. D. and Swerdlow, S. H., Gene expression profiling of Epstein-Barr Virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Diagn. Mol. Pathol. 2007. 16: 158-168.
67. Capello, D., Rossi, D. and Gaidano, G., Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis. Hematol. Oncol. 2005. 23: 61-67.